Search by Drug Name or NDC
NDC 43742-2079-01 INFL Combination 6; 30; 2; 30; 30; 9; 10; 10; 10; 10; 3; 30; 30 [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL Details
INFL Combination 6; 30; 2; 30; 30; 9; 10; 10; 10; 10; 3; 30; 30 [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
INFL Combination is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is ACONITUM NAPELLUS WHOLE; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, F.
Product Information
| NDC | 43742-2079 |
|---|---|
| Product ID | 43742-2079_83a1759f-f2de-4ef4-874a-75e73a8b7824 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | INFL Combination |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Adenoviren Nosode, Influenzinum 2022-2023, Bryonia, Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 6; 30; 2; 30; 30; 9; 10; 10; 10; 10; 3; 30; 30 |
| Active Ingredient Units | [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL |
| Substance Name | ACONITUM NAPELLUS WHOLE; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, F |
| Labeler Name | Deseret Biologicals, Inc. |
| Pharmaceutical Class | Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED HOMEOPATHIC |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43742-2079-01 (43742207901)
| NDC Package Code | 43742-2079-1 |
|---|---|
| Billing NDC | 43742207901 |
| Package | 30 mL in 1 BOTTLE, DROPPER (43742-2079-1) |
| Marketing Start Date | 2023-02-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |